Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor-positive Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer
Interventions: DRUG: exemestane|DRUG: triptorelin pamoate|DRUG: capecitabine|DRUG: methotrexate|DRUG: vinorelbine tartrate|DRUG: paclitaxel|PROCEDURE: therapeutic conventional surgery|RADIATION: radiation therapy|OTHER: laboratory biomarker analysis
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)